3D printing of tailored veterinary dual-release tablets: a semi-solid extrusion approach for metoclopramide
RSC Pharmaceutics · 2025 · 2 (2) · 413-426
DOI: 10.1039/d4pm00322e ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2025. Verfasst von Rathna Mathiyalagan und 10 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Business Finland, Suomen Farmaseuttinen Yhdistys, Research Council of Finland.
Abstract (Originalsprache)
3D printable metoclopramide-containing ink formulation was developed for additive manufacturing of dual-release dosage forms suitable for tailored medicine to small animals.
Förderung
- Business Finland
- Suomen Farmaseuttinen Yhdistys
- Research Council of Finland
Zitieren
APA
Mathiyalagan, R., Westerlund, M., Mahran, A., Altunay, R., Suuronen, J., Palo, M., Nyman, J. O., Immonen, E., Rosenholm, J. M., Monaco, E., & Wang, X. (2025). 3D printing of tailored veterinary dual-release tablets: a semi-solid extrusion approach for metoclopramide. RSC Pharmaceutics, 2(2), 413-426. https://doi.org/10.1039/d4pm00322e
Vancouver
Mathiyalagan R, Westerlund M, Mahran A, Altunay R, Suuronen J, Palo M, et al. 3D printing of tailored veterinary dual-release tablets: a semi-solid extrusion approach for metoclopramide. RSC Pharmaceutics. 2025;2(2):413-426. doi:10.1039/d4pm00322e
BibTeX
@article{Mathiyalagan2025,
author = {Mathiyalagan, Rathna and Westerlund, Max and Mahran, Alaa and Altunay, Rabia and Suuronen, Jarkko and Palo, Mirja and Nyman, Johan O. and Immonen, Eero and Rosenholm, Jessica M. and Monaco, Erica and Wang, Xiaoju},
title = {3D printing of tailored veterinary dual-release tablets: a semi-solid extrusion approach for metoclopramide},
journal = {RSC Pharmaceutics},
year = {2025},
volume = {2},
number = {2},
pages = {413--426},
doi = {10.1039/d4pm00322e}
}
EUVIMED